ReviewFrontiers in immunology

COVID-19 in B Cell-Depleted Patients After Rituximab: A Diagnostic and Therapeutic Challenge.

Anna Furlan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.